ESC Premium Access

Will the availability of specific reversal agents change the use of NOACs?

Congress Presentation

About the speaker

Professor Freek Verheugt

Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
22 presentations
0 follower

3 more presentations in this session

When should I use reversal agents for NOACs?

Speaker: Professor G. Lip (Liverpool, GB)


Reversal of the thrombin inhibitor dabigatran.

Speaker: Associate Professor A. Niessner (Vienna, AT)


Reversal of FXa inhibitors.

Speaker: Associate Professor S. Wassmann (Munich, DE)


Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Professor F. Verheugt, Professor G. Lip, Associate Professor A. Niessner, Associate Professor S. Wassmann

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb